276 related articles for article (PubMed ID: 32873520)
1. Systemic inflammation as fuel for acute liver injury in COVID-19.
Effenberger M; Grander C; Grabherr F; Griesmacher A; Ploner T; Hartig F; Bellmann-Weiler R; Joannidis M; Zoller H; Weiss G; Adolph TE; Tilg H
Dig Liver Dis; 2021 Feb; 53(2):158-165. PubMed ID: 32873520
[TBL] [Abstract][Full Text] [Related]
2. Liver Biochemistries in Hospitalized Patients With COVID-19.
Bloom PP; Meyerowitz EA; Reinus Z; Daidone M; Gustafson J; Kim AY; Schaefer E; Chung RT
Hepatology; 2021 Mar; 73(3):890-900. PubMed ID: 32415860
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hepatic enzymes activities in COVID-19 patients.
Hwaiz R; Merza M; Hamad B; HamaSalih S; Mohammed M; Hama H
Int Immunopharmacol; 2021 Aug; 97():107701. PubMed ID: 33930704
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
5. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19.
Wang Y; Liu S; Liu H; Li W; Lin F; Jiang L; Li X; Xu P; Zhang L; Zhao L; Cao Y; Kang J; Yang J; Li L; Liu X; Li Y; Nie R; Mu J; Lu F; Zhao S; Lu J; Zhao J
J Hepatol; 2020 Oct; 73(4):807-816. PubMed ID: 32437830
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
8. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers of cytokine storm as red flags for severe and fatal COVID-19 cases: A living systematic review and meta-analysis.
Melo AKG; Milby KM; Caparroz ALMA; Pinto ACPN; Santos RRP; Rocha AP; Ferreira GA; Souza VA; Valadares LDA; Vieira RMRA; Pileggi GS; Trevisani VFM
PLoS One; 2021; 16(6):e0253894. PubMed ID: 34185801
[TBL] [Abstract][Full Text] [Related]
10. Profiling of inflammatory biomarkers in mild to critically ill severe acute respiratory syndrome corona virus-19 (SARS Covid-19) patients from Karachi, Pakistan.
Alam JM; Asghar SS; Ali H; Mahmood SR; Ansari MA
Pak J Pharm Sci; 2021 Jan; 34(1(Special)):429-433. PubMed ID: 34275790
[TBL] [Abstract][Full Text] [Related]
11. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
[TBL] [Abstract][Full Text] [Related]
12. Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
Bülow Anderberg S; Luther T; Berglund M; Larsson R; Rubertsson S; Lipcsey M; Larsson A; Frithiof R; Hultström M
Cytokine; 2021 Feb; 138():155389. PubMed ID: 33348065
[TBL] [Abstract][Full Text] [Related]
13. Application value of artificial liver support system in the treatment of cytokine storm in patients with COVID-19.
Xia Q; Xu K; Yu L; Zhang H; Li L
Int Immunopharmacol; 2021 Jan; 90():107120. PubMed ID: 33162345
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal relationship of liver injury with inflammation biomarkers in COVID-19 hospitalized patients using a joint modeling approach.
Diaz-Louzao C; Barrera-Lopez L; Lopez-Rodriguez M; Casar C; Vazquez-Agra N; Pernas-Pardavila H; Marques-Afonso A; Vidal-Vazquez M; Montoya JG; Andrade AH; Fernandez-Castro I; Varela P; Gonzalez-Quintela A; Otero E; Gude F; Cadarso-Suarez C; Tome S
Sci Rep; 2022 Apr; 12(1):5547. PubMed ID: 35365705
[TBL] [Abstract][Full Text] [Related]
15. Sources and clinical significance of aspartate aminotransferase increases in COVID-19.
Aloisio E; Colombo G; Arrigo C; Dolci A; Panteghini M
Clin Chim Acta; 2021 Nov; 522():88-95. PubMed ID: 34411557
[TBL] [Abstract][Full Text] [Related]
16. An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis.
Liu Y; Chen D; Hou J; Li H; Cao D; Guo M; Ling Y; Gao M; Zhou Y; Wan Y; Zhu Z
Cytokine; 2021 Feb; 138():155365. PubMed ID: 33246770
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
Liao FL; Peng DH; Chen W; Hu HN; Tang P; Liu YY; Luo Y; Yao T
J Med Virol; 2021 Apr; 93(4):2365-2373. PubMed ID: 33314141
[TBL] [Abstract][Full Text] [Related]
18. Associations between markers of liver injury and cytokine markers for insulin sensitivity and inflammation in middle-aged Japanese men not being treated for metabolic diseases.
Mochizuki K; Misaki Y; Miyauchi R; Takabe S; Shimada M; Ichikawa Y; Goda T
J Nutr Sci Vitaminol (Tokyo); 2011; 57(6):409-17. PubMed ID: 22472283
[TBL] [Abstract][Full Text] [Related]
19. Artificial Intelligence Predicts Severity of COVID-19 Based on Correlation of Exaggerated Monocyte Activation, Excessive Organ Damage and Hyperinflammatory Syndrome: A Prospective Clinical Study.
Krysko O; Kondakova E; Vershinina O; Galova E; Blagonravova A; Gorshkova E; Bachert C; Ivanchenko M; Krysko DV; Vedunova M
Front Immunol; 2021; 12():715072. PubMed ID: 34539644
[TBL] [Abstract][Full Text] [Related]
20. Routine blood tests as a potential diagnostic tool for COVID-19.
Ferrari D; Motta A; Strollo M; Banfi G; Locatelli M
Clin Chem Lab Med; 2020 Jun; 58(7):1095-1099. PubMed ID: 32301746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
